BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 22716170)

  • 1. [Interactions between glucocorticoids and warfarin in chronic inflammatory (autoimmune) diseases].
    Hromádková L; Vlček J
    Vnitr Lek; 2012 May; 58(5):354-6. PubMed ID: 22716170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Warfarin and miconazole oral gel interactions: analysis and therapy recommendations based on clinical data and a pharmacokinetic model.
    Miki A; Ohtani H; Sawada Y
    J Clin Pharm Ther; 2011 Dec; 36(6):642-50. PubMed ID: 21143257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding.
    Delaney JA; Opatrny L; Brophy JM; Suissa S
    CMAJ; 2007 Aug; 177(4):347-51. PubMed ID: 17698822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probable interaction between warfarin and marijuana smoking.
    Yamreudeewong W; Wong HK; Brausch LM; Pulley KR
    Ann Pharmacother; 2009 Jul; 43(7):1347-53. PubMed ID: 19531696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term drug interaction of warfarin with amiodarone].
    Hirmerová J; Suchý D; Mádr T
    Cas Lek Cesk; 2003 Jan; 142(1):39-42. PubMed ID: 12693297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of drug interactions on bleeding risk associated with warfarin therapy in hospitalized patients.
    Hauta-Aho M; Tirkkonen T; Vahlberg T; Laine K
    Ann Med; 2009; 41(8):619-28. PubMed ID: 19711211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Warfarin therapy: evolving strategies in anticoagulation.
    Horton JD; Bushwick BM
    Am Fam Physician; 1999 Feb; 59(3):635-46. PubMed ID: 10029789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefit versus risk for oral, inhaled, and nasal glucocorticosteroids.
    Mortimer KJ; Tattersfield AE
    Immunol Allergy Clin North Am; 2005 Aug; 25(3):523-39. PubMed ID: 16054541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of acetaminophen on international normalized ratio in patients receiving warfarin therapy.
    Hughes GJ; Patel PN; Saxena N
    Pharmacotherapy; 2011 Jun; 31(6):591-7. PubMed ID: 21923443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An adverse interaction between warfarin and capecitabine: a case report and review of the literature.
    Copur MS; Ledakis P; Bolton M; Morse AK; Werner T; Norvell M; Muhvic J; Chu E
    Clin Colorectal Cancer; 2001 Nov; 1(3):182-4. PubMed ID: 12450435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical workload, risk factors and complications in patients on warfarin with gastrointestinal bleeding.
    Som R; Gossage JA; Crane A; Rowe PH
    Int J Surg; 2010; 8(1):52-5. PubMed ID: 19883802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial.
    Eikelboom JW; Wallentin L; Connolly SJ; Ezekowitz M; Healey JS; Oldgren J; Yang S; Alings M; Kaatz S; Hohnloser SH; Diener HC; Franzosi MG; Huber K; Reilly P; Varrone J; Yusuf S
    Circulation; 2011 May; 123(21):2363-72. PubMed ID: 21576658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible interaction between warfarin and cranberry juice.
    Suvarna R; Pirmohamed M; Henderson L
    BMJ; 2003 Dec; 327(7429):1454. PubMed ID: 14684645
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk factors in patients with gastrointestinal bleeding due to warfarin usage.
    Beyan E; Beyan C; Vaizoğlu SA
    Int J Surg; 2010; 8(3):257-8. PubMed ID: 20060938
    [No Abstract]   [Full Text] [Related]  

  • 16. Potential glucosamine-warfarin interaction resulting in increased international normalized ratio: case report and review of the literature and MedWatch database.
    Knudsen JF; Sokol GH
    Pharmacotherapy; 2008 Apr; 28(4):540-8. PubMed ID: 18363538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient factors that influence warfarin dose response.
    White PJ
    J Pharm Pract; 2010 Jun; 23(3):194-204. PubMed ID: 21507814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Warfarin--topical salicylate interactions: case reports.
    Ramanathan M
    Med J Malaysia; 1995 Sep; 50(3):278-9. PubMed ID: 8926909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predisposing preventable factors in patients with bleeding due to warfarin usage: Evaluation of 114 patients.
    Beyan E; Beyan C; Vaizoğlu SA
    Clin Appl Thromb Hemost; 2010 Dec; 16(6):684-7. PubMed ID: 19520686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrointestinal safety of nonsteroidal antiinflammatory drugs and selective cyclooxygenase-2 inhibitors in patients on warfarin.
    Cheetham TC; Levy G; Niu F; Bixler F
    Ann Pharmacother; 2009 Nov; 43(11):1765-73. PubMed ID: 19809010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.